The 'Wolverine Protocol' (BPC-157 & TB-500 40mg Pen): Tendon, Joint & Aesthetic Recovery
Combining Pentadecapeptide BPC-157 with Thymosin Beta-4 (TB-500) creates a powerful angiogenic and fibroblast-migrating synergy used by elite athletes and aesthetic surgery clinics across Europe.
GEO: Sports Rehab, Aesthetic Surgery Recovery, Spain / France / Italy, Pro Athletics
Scientific Review: Dr. Lukas V. Meyer, Ph.D. (Head of Analytical Chemistry, Synedica Basel R&D)
- Dual regenerative matrix: 20mg BPC-157 + 20mg TB-500 (40mg total across 4 sterile cartridges).
- Up-regulates VEGF angiogenesis, GH receptor expression on fibroblasts, and actin polymerization.
- Widely adopted in European aesthetic clinics post-blepharoplasty, SMAS lifting, CO2 laser, and thread lifts.
- Systemic mucosal repair for gut barrier integrity and chronic inflammation reduction.
1. How BPC-157 and TB-500 Work Together ('Wolverine Synergy')
Tendons and ligaments have notoriously poor blood supply, leading to slow healing and scar tissue formation. BPC-157 stimulates VEGF to build new microvascular networks and increases growth hormone receptor density on local fibroblasts. Simultaneously, TB-500 regulates cellular actin, allowing repair cells to migrate rapidly into the injured site while suppressing pro-inflammatory cytokines (TNF-α, IL-6).
2. Dosing & Click Protocol for Sports & Aesthetic Clinics
Each click of the Synedica BPC-157 & TB-500 pen delivers 0.167 mg (167 mcg) of combined peptides:
| Indication / Research Scope | Daily / EOD Dose | Pen Clicks | Cycle Duration |
|---|---|---|---|
| Aesthetic / Post-Procedure Recovery | 0.50 mg / day | 3 clicks daily | 2–4 weeks |
| Active Tendon / Joint Rehabilitation | 0.67–1.0 mg / day | 4–6 clicks daily | 4–8 weeks |
| Gut Barrier & Systemic Anti-Inflammation | 0.50 mg / day | 3 clicks daily | 4–6 weeks |